European Journal of Surgical Oncology
Volume 36, Issue 4 , Pages 340-344 , April 2010

Quality assurance in rectal cancer treatment in the Netherlands: A catch up compared to colon cancer treatment

  • W. van Gijn

      Affiliations

    • Department of Surgery, Leiden University Medical Center, K6-R, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • P. Krijnen

      Affiliations

    • Leiden Cancer Registry, Comprehensive Cancer Centre West (IKW), Leiden, The Netherlands
  • ,
  • V.E.P.P. Lemmens

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Centre South (IKZ), Eindhoven, The Netherlands
  • ,
  • M. den Dulk

      Affiliations

    • Department of Surgery, Haga Hospital, The Hague, The Netherlands
  • ,
  • H. Putter

      Affiliations

    • Department of Statistics, Leiden University Medical Center, Leiden, The Netherlands
  • ,
  • C.J.H. van de Velde

      Affiliations

    • Department of Surgery, Leiden University Medical Center, K6-R, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 71 526 2309; fax: +31 71 526 6750.

,Accepted 19 October 2009.

References 

  1. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–646
  2. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2(8514):996–999
  3. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246(5):693–701
  4. den Dulk M, Krijnen P, Marijnen CA, et al. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. Eur J Cancer. 2008;44(12):1710–1716
  5. Gatta G, Faivre J, Capocaccia R, et al. Survival of colorectal cancer patients in Europe during the period 1978–1989. Eur J Cancer. 1998;34(14):2176–2183
  6. Schouten LJ, Hoppener P, van den Brandt PA, et al. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol. 1993;22(3):369–376
  7. Krijnen P, den Dulk M, Meershoek-Klein KE, et al. Improved survival after resectable non-cardia gastric cancer in The Netherlands: the importance of surgical training and quality control. Eur J Surg Oncol. 2009;35(7):715–720
  8. Peeters KC, van de Velde C. Surgical quality assurance in breast, gastric and rectal cancer. J Surg Oncol. 2003;84(3):107–112
  9. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer. 2009;45(6):931–991
  10. van Gijn W, Wouters MW, Peeters KC, et al. Nationwide outcome registrations to improve quality of care in rectal surgery. An initiative of the European society of surgical oncology. J Surg Oncol. 2009;99(8):491–496
  11. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002;45(7):857–866
  12. Wibe A, Nationwide quality assurance of rectal cancer treatment, Colorectal congress, 28th November 2007, St. Gallen, Switzerland.
  13. Monz BU, Konig HH, Leidl R, et al. Cost effectiveness of adding folinic acid to fluorouracil plus levamisole as adjuvant chemotherapy in patients with colon cancer in Germany. Pharmacoeconomics. 2003;21(10):709–719
  14. West NP, Morris EJ, Rotimi O, et al. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol. 2008;9(9):857–865
  15. Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373(9666):821–828
  16. Dutch Surgical Colorectal Audit . Available from: http://www.dsca.nl

 W. van Gijn is supported by a joint ECCO fellowship funded by ESSO, ESTRO and EORTC.

PII: S0748-7983(09)00494-6

doi: 10.1016/j.ejso.2009.10.010

European Journal of Surgical Oncology
Volume 36, Issue 4 , Pages 340-344 , April 2010